Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

Rhea-AI Summary

Prestige Consumer Healthcare (NYSE:PBH) will release its fiscal 2026 second quarter and first half earnings on Thursday, November 6, 2025 before market open. The company will host a conference call the same morning at 8:30 a.m. ET to discuss results.

Investors can join a live webcast from the Investor Relations page at www.prestigeconsumerhealthcare.com or register to receive dial-in details and a unique PIN for phone participation. A replay of the call will be available on the Investor Relations page for approximately one week after the live event.

News Market Reaction

-0.51%

1 alert

-0.51% News Effect

On the day this news was published, PBH declined 0.51%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.

A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat^® and Summer’s Eve^® women's health products, BC^® and Goody's^® pain relievers, Clear Eyes^® and TheraTears^® eye care products, DenTek^® specialty oral care products, Dramamine^® motion sickness treatments, Fleet^® enemas and glycerin suppositories, Chloraseptic^® and Luden's^® sore throat treatments and drops, Compound W^® wart treatments, Little Remedies^® pediatric over-the-counter products, Boudreaux’s Butt Paste^® diaper rash ointments, Nix^® lice treatment, Debrox^® earwax remover, Gaviscon^® antacid in Canada, and Hydralyte^® rehydration products and the Fess^® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com

FAQ

When will Prestige Consumer Healthcare (PBH) release fiscal 2026 Q2 results?

PBH will release fiscal 2026 Q2 and first half results on November 6, 2025 before market open.

What time is the PBH earnings conference call on November 6, 2025?

The conference call is scheduled for 8:30 a.m. ET on the morning of November 6, 2025.

How can investors access the PBH November 6, 2025 webcast?

Join the live Internet webcast from the Investor Relations page at www.prestigeconsumerhealthcare.com.

How do I join the PBH conference call by phone?

Register via the company’s conference call registration link to receive dial-in details and a unique PIN before the call.

Will there be a replay of the PBH November 6, 2025 earnings call?

Yes. A conference call replay will be available on the Investor Relations page for about one week after the live call.